{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T13:23:44Z","timestamp":1783949024813,"version":"3.55.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"JSPS KAKENHI","award":["21790583"],"award-info":[{"award-number":["21790583"]}]},{"name":"JSPS KAKENHI","award":["23790697"],"award-info":[{"award-number":["23790697"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jdcjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Diabetes and its Complications"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.jdiacomp.2016.02.006","type":"journal-article","created":{"date-parts":[[2016,2,13]],"date-time":"2016-02-13T21:26:13Z","timestamp":1455398773000},"page":"923-927","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Serum lipoprotein(a) levels and diabetic nephropathy among Japanese patients with type 2 diabetes mellitus"],"prefix":"10.1016","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4409-4761","authenticated-orcid":false,"given":"Hidenori","family":"Senba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Furukawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takenori","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuji","family":"Niiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teruki","family":"Miyake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teruhisa","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masamoto","family":"Torisu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisaka","family":"Minami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Miyaoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morikazu","family":"Onji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiko","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bunzo","family":"Matsuura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Tanigawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoichi","family":"Hiasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Miyake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdiacomp.2016.02.006_bb0005","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/j.1699-0463.1963.tb01808.x","article-title":"A new serum type system in man: The Lp system","volume":"59","author":"Berg","year":"1963","journal-title":"Acta Pathologica et Microbiologica Scandinavica"},{"key":"10.1016\/j.jdiacomp.2016.02.006_bb0010","doi-asserted-by":"crossref","first-page":"105","DOI":"10.4239\/wjd.v3.i5.105","article-title":"Lipoprotein(a) in type 2 diabetic subjects and its relationship to diabetic microvascular complications","volume":"3","author":"Chandni","year":"2012","journal-title":"World Journal of Diabetes"},{"key":"10.1016\/j.jdiacomp.2016.02.006_bb0015","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/oxfordjournals.aje.a116517","article-title":"Serum lipoprotein(a) levels in racially different populations","volume":"136","author":"Cobbaert","year":"1992","journal-title":"American Journal of Epidemiology"},{"key":"10.1016\/j.jdiacomp.2016.02.006_bb0020","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1681\/ASN.V981474","article-title":"Evidence for increased synthesis of lipoprotein(a) in the nephrotic syndrome","volume":"9","author":"De Sain-Van Der Velden","year":"1998","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1016\/j.jdiacomp.2016.02.006_bb0025","first-page":"657","article-title":"Lipoprotein(a) in South Indian type 2 diabetic subjects in relation to diabetic vascular complications","volume":"50","author":"Deepa","year":"2002","journal-title":"Journal of the Association of Physicians of India"},{"key":"10.1016\/j.jdiacomp.2016.02.006_bb0030","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1038\/sj.ki.5002131","article-title":"In vivo turnover study demonstrates diminished clearance of lipoprotein(a) in hemodialysis patients","volume":"71","author":"Frischmann","year":"2007","journal-title":"Kidney International"},{"key":"10.1016\/j.jdiacomp.2016.02.006_bb0035","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/ki.1995.5","article-title":"Oxidized LDL and lipoprotein(a) stimulate renin release of juxtaglomerular cells","volume":"47","author":"Galle","year":"1995","journal-title":"Kidney International"},{"key":"10.1016\/j.jdiacomp.2016.02.006_bb0040","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/ki.1997.30","article-title":"Effect of HDL and atherogenic lipoproteins on formation of O2- and renin release in juxtaglomerular cells","volume":"51","author":"Galle","year":"1997","journal-title":"Kidney International"},{"key":"10.1016\/j.jdiacomp.2016.02.006_bb0045","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1046\/j.1523-1755.1999.00351.x","article-title":"Lp(a) and LDL induce apoptosis in human endothelial cells and in rabbit aorta: Role of oxidative stress","volume":"55","author":"Galle","year":"1999","journal-title":"Kidney International"},{"key":"10.1016\/j.jdiacomp.2016.02.006_bb0050","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1093\/ndt\/12.7.1330","article-title":"Lipoprotein(a) induces glomerular superoxide anion production","volume":"12","author":"Greiber","year":"1997","journal-title":"Nephrology, Dialysis, Transplantation"},{"key":"10.1016\/j.jdiacomp.2016.02.006_bb0055","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1161\/01.ATV.13.2.205","article-title":"Cardiovascular risk factors in non-insulin-dependent diabetic subjects with microalbuminuria","volume":"13","author":"Haffner","year":"1993","journal-title":"Arteriosclerosis & Thrombosis"},{"key":"10.1016\/j.jdiacomp.2016.02.006_bb0060","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/jdi.12319","article-title":"A new Classification of Diabetic Nephropathy 2014: A report from Joint Committee on Diabetic Nephropathy","volume":"6","author":"Haneda","year":"2015","journal-title":"Journal of Diabetes Investigation"},{"key":"10.1016\/j.jdiacomp.2016.02.006_bb0065","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/j.1365-2362.1993.tb00969.x","article-title":"Lipoprotein(a) levels in relation to diabetic complications in patients with non-insulin-dependent diabetes","volume":"23","author":"Heesen","year":"1993","journal-title":"European Journal of Clinical Investigation"},{"key":"10.1016\/j.jdiacomp.2016.02.006_bb0070","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1046\/j.1365-2362.1997.1420684.x","article-title":"Relationship between lipoprotein(a) phenotypes and albumin excretion rate in non-insulin-dependent diabetes mellitus: Protective effect of 'null' phenotype?","volume":"27","author":"Hern\u00e1ndez","year":"1997","journal-title":"European Journal of Clinical Investigation"},{"key":"10.1016\/j.jdiacomp.2016.02.006_bb0075","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2337\/diacare.18.2.241","article-title":"Prospective study of lipoprotein(a) as a risk factor for atherosclerotic cardiovascular disease in patients with diabetes","volume":"18","author":"Hiraga","year":"1995","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2016.02.006_bb0080","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1445-5994.1992.tb02119.x","article-title":"Lipoprotein(a) levels in chronic renal disease states, dialysis and transplantation","volume":"22","author":"Irish","year":"1992","journal-title":"Australian and New Zealand Journal of Medicine"},{"key":"10.1016\/j.jdiacomp.2016.02.006_bb0085","first-page":"1034","article-title":"Clinical practice guidebook for diagnosis and treatment of chronic kidney disease 2012","volume":"54","author":"Japan Nephrology Society","year":"2012","journal-title":"Nippon Jinzo Gakkai Shi"},{"key":"10.1016\/j.jdiacomp.2016.02.006_bb0090","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.2337\/dc06-0546","article-title":"Lipoprotein(a) as a predictor of cardiovascular disease in a prospectively followed cohort of patients with type 1 diabetes","volume":"29","author":"Kollerits","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2016.02.006_bb0100","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1365-2796.2012.02592.x","article-title":"Lipoprotein(a): Resurrected by genetics","volume":"273","author":"Kronenberg","year":"2013","journal-title":"Journal of Internal Medicine"},{"key":"10.1016\/j.jdiacomp.2016.02.006_bb0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0272-6386(96)90026-8","article-title":"Lipoprotein(a) in renal disease","volume":"27","author":"Kronenberg","year":"1996","journal-title":"American Journal of Kidney Diseases"},{"key":"10.1016\/j.jdiacomp.2016.02.006_bb0105","doi-asserted-by":"crossref","first-page":"e114397","DOI":"10.1371\/journal.pone.0114397","article-title":"Plasma lipoprotein(a) levels are associated with mild renal impairment in type 2 diabetics independent of albuminuria","volume":"9","author":"Lin","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.jdiacomp.2016.02.006_bb0110","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.2169\/internalmedicine.50.6216","article-title":"Circulating ApoE level is independently associated with urinary albumin excretion in type 2 diabetic patients","volume":"50","author":"Ling","year":"2011","journal-title":"Internal Medicine"},{"key":"10.1016\/j.jdiacomp.2016.02.006_bb0115","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1161\/01.ATV.10.2.240","article-title":"Lipoprotein(a), fibrin binding, and plasminogen activation","volume":"10","author":"Loscalzo","year":"1990","journal-title":"Arteriosclerosis"},{"key":"10.1016\/j.jdiacomp.2016.02.006_bb0120","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1016\/S0022-2275(20)37461-7","article-title":"Differences in Lp(a) concentrations and apo(a) polymorphs between black and white Americans","volume":"37","author":"Marcovina","year":"1996","journal-title":"The Journal of Lipid Research"},{"key":"10.1016\/j.jdiacomp.2016.02.006_bb0125","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/330132a0","article-title":"cDNA sequence of human apolipoprotein(a) is homologous to plasminogen","volume":"330","author":"McLean","year":"1987","journal-title":"Nature"},{"key":"10.1016\/j.jdiacomp.2016.02.006_bb0130","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1046\/j.1523-1755.1999.00367.x","article-title":"Lipoprotein(a) stimulates growth of human mesangial cells and induces activation of phospholipase C via pertussis toxin-sensitive G proteins","volume":"55","author":"Mondorf","year":"1999","journal-title":"Kidney International"},{"key":"10.1016\/j.jdiacomp.2016.02.006_bb0135","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.2337\/diacare.16.10.1411b","article-title":"Change of lipoprotein(a) and coagulathre or fibrinolytic parameters in diabetic patients with nephropathy","volume":"16","author":"Nagai","year":"1993","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2016.02.006_bb0140","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/jdi.12183","article-title":"Changes in oral antidiabetic prescriptions and improved glycemic control during the years 2002-2011 in Japan (JDDM32)","volume":"5","author":"Oishi","year":"2014","journal-title":"Journal of Diabetes Investigation"},{"key":"10.1016\/j.jdiacomp.2016.02.006_bb0145","doi-asserted-by":"crossref","first-page":"397","DOI":"10.2217\/clp.12.46","article-title":"Lipoprotein(a) and cardiovascular disease in diabetic patients","volume":"7","author":"Qi","year":"2012","journal-title":"Journal of Clinical Lipidology"},{"key":"10.1016\/j.jdiacomp.2016.02.006_bb0150","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2337\/diacare.17.3.189","article-title":"Relationship between lipoprotein profile and urinary albumin excretion in type II diabetic patients with stable metabolic control","volume":"17","author":"Reverter","year":"1994","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2016.02.006_bb0155","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0021-9150(92)90271-H","article-title":"Lipoprotein(a) at birth, in blacks and whites","volume":"92","author":"Rifai","year":"1992","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jdiacomp.2016.02.006_bb0160","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1159\/000112225","article-title":"Effects of renal replacement therapy on plasma lipoprotein(a) levels","volume":"28","author":"Rosas","year":"2008","journal-title":"American Journal of Nephrology"},{"key":"10.1016\/j.jdiacomp.2016.02.006_bb0165","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/BF00403377","article-title":"Association of elevated lipoprotein(a) levels and coronary heart disease in NIDDM patients. Relationship with apolipoprotein(a) phenotypes","volume":"37","author":"Ruiz","year":"1994","journal-title":"Diabetologia"},{"key":"10.1016\/j.jdiacomp.2016.02.006_bb0170","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.2337\/diacare.28.7.1718","article-title":"Prospective study of lipoprotein(a) as a risk factor for deteriorating renal function in type 2 diabetic patients with overt proteinuria","volume":"28","author":"Song","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2016.02.006_bb0175","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0021-9150(90)90135-6","article-title":"Alterations of lipoprotein(a) in patients with diabetic nephropathy","volume":"83","author":"Takegoshi","year":"1990","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jdiacomp.2016.02.006_bb0180","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s13340-010-0006-7","article-title":"Report of the committee on the classification and diagnostic criteria of diabetes mellitus","volume":"1","author":"The Committee of the Japan Diabetes Society on the diagnostic criteria of diabetes mellitus","year":"2010","journal-title":"Diabetology International"},{"key":"10.1016\/j.jdiacomp.2016.02.006_bb0185","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1001\/jama.2009.1063","article-title":"Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality","volume":"302","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.jdiacomp.2016.02.006_bb0190","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1046\/j.1365-2362.1996.132283.x","article-title":"Hyperlipoprotein(a)aemia in nephrotic syndrome","volume":"26","author":"Thiery","year":"1996","journal-title":"European Journal of Clinical Investigation"},{"key":"10.1016\/j.jdiacomp.2016.02.006_bb0195","first-page":"93","article-title":"Relationship between lipoprotein(a) and micro\/macro complications in type 2 diabetes mellitus: A forgotten target","volume":"12","author":"Toro","year":"2015","journal-title":"Journal of Geriatric Cardiology"},{"key":"10.1016\/j.jdiacomp.2016.02.006_bb0200","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.clinbiochem.2009.03.013","article-title":"Differential dyslipidemia associated with albuminuria in type 2 diabetic patients in Taiwan","volume":"42","author":"Tseng","year":"2009","journal-title":"Clinical Biochemistry"},{"key":"10.1016\/j.jdiacomp.2016.02.006_bb0205","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1126\/science.2530631","article-title":"The mysteries of lipoprotein(a)","volume":"246","author":"Utermann","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.jdiacomp.2016.02.006_bb0210","doi-asserted-by":"crossref","first-page":"989","DOI":"10.2337\/dc06-1859","article-title":"Microalbuminuria is common in Japanese type 2 diabetic patients\u2014a nationwide survey from the Japan Diabetes Clinical Data Management Study Group (JDDM 10)","volume":"30","author":"Yokoyama","year":"2007","journal-title":"Diabetes Care"}],"container-title":["Journal of Diabetes and its Complications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105687271600057X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105687271600057X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T10:19:56Z","timestamp":1718360396000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S105687271600057X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S105687271600057X"],"URL":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2016.02.006","relation":{},"ISSN":["1056-8727"],"issn-type":[{"value":"1056-8727","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum lipoprotein(a) levels and diabetic nephropathy among Japanese patients with type 2 diabetes mellitus","name":"articletitle","label":"Article Title"},{"value":"Journal of Diabetes and its Complications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2016.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}